[High-dose insulin therapy].
Yoichi
Y
Shirakawa
D000319:Adrenergic beta-Antagonists / Q000506:poisoning*; D000818:Animals; D002121:Calcium Channel Blockers / Q000506:poisoning*; D002316:Cardiotonic Agents; D005947:Glucose / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007003:Hypoglycemia; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D011188:Potassium / Q000008:administration & dosage / Q000009:adverse effects; D020551:Pulse Therapy, Drug; D012770:Shock, Cardiogenic / Q000139:chemically induced* / Q000188:drug therapy*; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium